Ancora Advisors LLC - PROVECTUS BIOPHARMACEUTICALS ownership

PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 8 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Ancora Advisors LLC ownership history of PROVECTUS BIOPHARMACEUTICALS
ValueSharesWeighting
Q2 2023$865
-31.5%
7,6500.0%0.00%
Q1 2023$1,262
+126100.0%
7,6500.0%0.00%
Q4 2022$1
-99.9%
7,650
-47.8%
0.00%
Q3 2022$1,0000.0%14,6500.0%0.00%
Q2 2022$1,0000.0%14,6500.0%0.00%
Q1 2022$1,0000.0%14,650
-0.8%
0.00%
Q4 2021$1,0000.0%14,7700.0%0.00%
Q3 2021$1,0000.0%14,770
+0.8%
0.00%
Q2 2021$1,0000.0%14,6500.0%0.00%
Q1 2021$1,00014,6500.00%
Other shareholders
PROVECTUS BIOPHARMACEUTICALS shareholders Q3 2021
NameSharesValueWeighting ↓
HOME FEDERAL BANK OF TENNESSEE 100,000$6,0000.00%
LEE DANNER & BASS INC 50,000$3,0000.00%
Ancora Advisors LLC 14,650$1,0000.00%
Diversified Trust Co 50,000$3,0000.00%
CAPTRUST FINANCIAL ADVISORS 57,659$3,0000.00%
ACADEMY CAPITAL MANAGEMENT INC/TX 20,000$1,0000.00%
HUNTINGTON NATIONAL BANK 1$00.00%
View complete list of PROVECTUS BIOPHARMACEUTICALS shareholders